Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-3-27
pubmed:abstractText
Nebivolol (NEB) is a [beta]1-receptor blocker with nitric oxide-dependent vasodilating properties. NEB-induced nitric oxide release is mediated through the estrogen receptor.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Arginine, http://linkedlifedata.com/resource/pubmed/chemical/Benzopyrans, http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations, http://linkedlifedata.com/resource/pubmed/chemical/Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor Modulators, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Receptor beta, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, http://linkedlifedata.com/resource/pubmed/chemical/Ethanolamines, http://linkedlifedata.com/resource/pubmed/chemical/Metoprolol, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Nitrites, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/arginine methyl ester, http://linkedlifedata.com/resource/pubmed/chemical/fulvestrant, http://linkedlifedata.com/resource/pubmed/chemical/nebivolol
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1473-5598
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
517-26
pubmed:meshHeading
pubmed-meshheading:19330906-Adenocarcinoma, pubmed-meshheading:19330906-Adrenergic beta-Antagonists, pubmed-meshheading:19330906-Antihypertensive Agents, pubmed-meshheading:19330906-Arginine, pubmed-meshheading:19330906-Benzopyrans, pubmed-meshheading:19330906-Breast Neoplasms, pubmed-meshheading:19330906-Cell Line, pubmed-meshheading:19330906-Cell Line, Tumor, pubmed-meshheading:19330906-Cell Size, pubmed-meshheading:19330906-Dose-Response Relationship, Drug, pubmed-meshheading:19330906-Drug Combinations, pubmed-meshheading:19330906-Elasticity, pubmed-meshheading:19330906-Endothelial Cells, pubmed-meshheading:19330906-Estradiol, pubmed-meshheading:19330906-Estrogen Antagonists, pubmed-meshheading:19330906-Estrogen Receptor Modulators, pubmed-meshheading:19330906-Estrogen Receptor beta, pubmed-meshheading:19330906-Estrogens, pubmed-meshheading:19330906-Ethanolamines, pubmed-meshheading:19330906-Female, pubmed-meshheading:19330906-Genes, Reporter, pubmed-meshheading:19330906-Humans, pubmed-meshheading:19330906-Metoprolol, pubmed-meshheading:19330906-Nanotechnology, pubmed-meshheading:19330906-Nitric Oxide, pubmed-meshheading:19330906-Nitrites, pubmed-meshheading:19330906-Tamoxifen, pubmed-meshheading:19330906-Time Factors, pubmed-meshheading:19330906-Transfection
pubmed:year
2009
pubmed:articleTitle
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
pubmed:affiliation
Department of Internal Medicine D, University of Muenster, Muenster, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't